554 related articles for article (PubMed ID: 20005001)
1. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
[TBL] [Abstract][Full Text] [Related]
2. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
3. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
[TBL] [Abstract][Full Text] [Related]
4. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
5. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
[TBL] [Abstract][Full Text] [Related]
6. Bet v 1 and its homologous food allergen Api g 1 stimulate dendritic cells from birch pollen-allergic individuals to induce different Th-cell polarization.
Smole U; Wagner S; Balazs N; Radauer C; Bublin M; Allmaier G; Hoffmann-Sommergruber K; Breiteneder H
Allergy; 2010 Nov; 65(11):1388-96. PubMed ID: 20557297
[TBL] [Abstract][Full Text] [Related]
7. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
[TBL] [Abstract][Full Text] [Related]
8. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
[TBL] [Abstract][Full Text] [Related]
9. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal digestion of Bet v 1-homologous food allergens destroys their mediator-releasing, but not T cell-activating, capacity.
Schimek EM; Zwölfer B; Briza P; Jahn-Schmid B; Vogel L; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Dec; 116(6):1327-33. PubMed ID: 16337467
[TBL] [Abstract][Full Text] [Related]
11. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G; Thunberg S; Kronqvist M; Grönlund H; Grönneberg R; Troye-Blomberg M; Akdis M; Fiebig H; Purohit A; Horak F; Reisinger J; Niederberger V; Akdis CA; Cromwell O; Pauli G; Valenta R; van Hage M
Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
[TBL] [Abstract][Full Text] [Related]
12. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
[TBL] [Abstract][Full Text] [Related]
13. A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation.
Kitzmüller C; Wallner M; Deifl S; Mutschlechner S; Walterskirchen C; Zlabinger GJ; Ferreira F; Bohle B
Allergy; 2012 Nov; 67(11):1375-82. PubMed ID: 22973879
[TBL] [Abstract][Full Text] [Related]
14. Molecular composition and biological activity of commercial birch pollen allergen extracts.
Focke M; Marth K; Valenta R
Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
[TBL] [Abstract][Full Text] [Related]
15. Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1.
Kitzmüller C; Nagl B; Deifl S; Walterskirchen C; Jahn-Schmid B; Zlabinger GJ; Bohle B
Allergy; 2012 May; 67(5):593-600. PubMed ID: 22188598
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy.
Wagner S; Radauer C; Bublin M; Hoffmann-Sommergruber K; Kopp T; Greisenegger EK; Vogel L; Vieths S; Scheiner O; Breiteneder H
J Allergy Clin Immunol; 2008 Jan; 121(1):246-52. PubMed ID: 17889932
[TBL] [Abstract][Full Text] [Related]
17. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
[TBL] [Abstract][Full Text] [Related]
18. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens.
Jahn-Schmid B; Radakovics A; Lüttkopf D; Scheurer S; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Jul; 116(1):213-9. PubMed ID: 15990797
[TBL] [Abstract][Full Text] [Related]
19. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
[TBL] [Abstract][Full Text] [Related]
20. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]